On November 17,MEDICA 2025 grandly opened,with ChoiceMMed's multi-series innovative solutions making a remarkable debut.At the exhibition,the quiet medical oxygen concentrator and portable oxygen concentrator showcased by ChoiceMMed became the focal point of the event.

Currently,Europe is facing the dual challenges of an accelerating aging population and a growing burden of respiratory diseases,which is driving rapid growth in the demand for respiratory health management and home medical equipment. 

Patients with chronic respiratory diseases such as COPD often require long-term oxygen therapy support,therefore placing higher demands on the convenience,quiet operation,and smart features of home oxygen therapy equipment. 

Driven by the needs of chronic respiratory disease management and market demand,ChoiceMMed has introduced its quiet medical oxygen concentrator and portable oxygen concentrator.The series has now completed the technical review phase for EU CE-MDR certification,and the company is committed to striving for its market launch by the end of 2025.The debut of ChoiceMMed's new oxygen concentrator series at MEDICA has offered global professional attendees a new choice for home respiratory health management.

Portable Oxygen Concentrator:Medical-Grade Oxygen Therapy,Unrestricted by Location 

For users requiring continuous oxygen therapy yet eager to maintain their normal pace of life,the ChoiceMMed portable oxygen concentrators will serve as their reliable companion for outings.During daily routines—be it neighborhood walks,shopping,or air travel—users can easily adjust the oxygen flow(levels 1-6)to match their activity level,from complete rest to being on the go. 

Quiet Medical Oxygen Concentrator:Crafting a Silent Environment for Home Recovery 

This oxygen concentrator is specifically designed for users requiring long-term home oxygen therapy,with particular attention to their need for a quiet environment.With a whisper-quiet operation of under 42 dB,it enables uninterrupted rest,both day and night.The optional nebulizer function and remote control,along with its compatibility with ventilators,enable it to meet diverse needs—from basic oxygen therapy to complex respiratory support. 

At this year's exhibition,ChoiceMMed also showcased an ultra-quiet oxygen concentrator prototype featuring cutting-edge technology.Boasting operation so quiet it nears the serenity of a night-time bedroom(below 32 dB),this concentrator embodies ChoiceMMed's visionary commitment to technological advancement in respiratory care.

Beyond oxygen concentrators,ChoiceMMed's pulse oximeters have also garnered significant attention.Maintaining a leading position in the global market,the exhibited oximeters encompass various forms including fingertip,handheld,wrist-worn style,and tabletop models.Driven by technological R&D,ChoiceMMed continuously innovates and upgrades its blood oxygen detection technology,expanding parameter monitoring to include respiratory rate and early atrial fibrillation screening.The introduction of Bluetooth series and 4G-enabled oximeters has further established a comprehensive blood oxygen product line.

ChoiceMMed has established subsidiaries in the United States,Germany,India,and other countries,with its products reaching over 100 nations and regions.The company is currently focusing on developing non-US markets,and this concentrated display of innovative products will further deepen its strategic presence in Europe.With the expanded operations of ChoiceMMed's German subsidiary and the development of its respiratory health product line,these oxygen concentrators integrating quiet oxygen therapy technology will form a second growth pillar following the pulse oximeter series.Soon to enter European households and medical institutions,they will provide users with smarter,more convenient respiratory health management experiences.